Skip to main content
Sign In
 

Brian D. Kavanagh Publications


 

Publications:

 

1.                Kavanagh BD: Burkitt's lymphoma. N. Carolina Med. J., 52(4):141, 1991.

2.           Kavanagh BD, Halperin EC, Rosenbaum LC, Shannon EM, Nilaver GJ. Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. Cancer, 69: 1315-1319, 1992.

3.           Kavanagh BD, Anscher M, Leopold K, Deutsch M, Gaydica E, Dodge R, Allen K, Allen DG, Staub E, Montana G, Crawford J, Wolfe W. Patterns of failure following combined modality therapy for esophageal cancer: 1984-1990. Int. J. Radiat. Oncol. Biol. Phys., 24(4): 633- 642,1992.

4.           Dewhirst MW, Ong E, Madwed D, Klitzman B, Secomb T, Brizel D, Bonaventura J, Rosner G, Kavanagh B, Edwards J, Gross J. Effects of the calcium channel blocker flunarizine on tumor microvascular hemodynamics and oxygenation. Radiat. Res., 132:61-68, 1992.

5.           Kavanagh BD, Coffey BE, Needham D, Hochmuth RM, Dewhirst MW. The effect of flunarizine on the viscosity of erythrocyte suspensions in conditions of extreme hypoxia, elevated lactate concentration, and acidosis. Br. J. Cancer, 67:734-741, 1993.

6.           Kavanagh BD, Montana GS, Crawford J, Wolfe WG, Anscher MS. Long term results of combined modality therapy for esophageal cancer. Radiation Oncology Investigations, 1:227-234, 1993.

7.           Kavanagh BD, Brizel DM, Leopold KA, Acker JC.  Radiation therapy for head and neck cancer in a patient with Takayasu's arteritis. Acta Oncologica, 33:73-74, 1994.

8.           Mak AC, Rich TA, Schultheiss TE, Kavanagh B, Ota DM, Rohmsdahl MM. Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid.  Int. J. Radiat. Oncol. Biol. Phys., 28:597-603, 1994.

9.           Kavanagh BD, Bentel GC, Montana GS. Soft tissue complication rates after low dose rate brachytherapy using customized perineal templates Int. J. Radiat. Onc. Biol. Phys. 30:508, 1994.

10.       Arthur D, Kaufman N, Schmidt-Ullrich R, Kavanagh B, Simpson P, Hill M, Ali M. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix.  Int. J. Radiat. Onc. Biol. Phys.  31:743-752, 1995.

11.       Kavanagh BD, Lin P-S, Chen P, Schmidt-Ullrich RK.  Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: A release from inhibition by epidermal growth factor.  Clin Canc Res 1:1557-1562, 1995.

12.       Zwicker RD, Atari NA, Kavanagh BD, Gieschen HL, Arnfield MR, Khandelwal SR, Schmidt-Ullrich RKA.  Clinical use of a digital simulator for rapid setup verification in high dose rate brachytherapy.  Int. J. Radiat. Oncol. Biol. Phys.  33:931-936, 1995.

13.       Lutz ST, Huang DT, Ferguson CF, Kavanagh BD, Lu J-D, Tercilla OT. A retrospective quality of life analysis in patients treated with palliative radiotherapy for advanced non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 37:117-122, 1997.

14.       Kavanagh BD, Gieschen H, Schmidt-Ullrich R, Arthur D, Zwicker R, Kaufman N, Goplerud D, Segreti E, West R.  A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 38: 561-8, 1997.

15.       Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh B, Contessa JN, Rorrer WK, Chen PB. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 15: 1191-1197, 1997.

16.       Kavanagh BD, Dent P, Schmidt-Ullrich RK, Chen P, Mikkelsen RB.  Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. Radiation Research  149: 579-587, 1998.

17.       Khandelwal SR, Kavanagh BD, Lin P-S, Truong QT, Lu J, Abraham DJ, Schmidt-Ullrich RK. RSR13, an allosteric effector of hemoglobin, and carbogen radiosensitize FSAII and SCCVII tumors in C3H mice.  Br J Cancer 79 (5/6): 814-820, 1999.

18.       Zwicker RD, Arthur DW, Kavanagh BD, Mohan R, Schmidt-Ullrich RK. Optimization of planar HDR implants. Int. J. Radiat. Oncol. Biol. Phys. 44(5): 1171-77, 1999.

19.       Cardinale RM, Wu Q, Benedict SH, Kavanagh BD, Bump E, Mohan R. Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 45(2): 515-520, 1999.

20.       Fulcher AS, O'Sullivan SG, Segreti E, Kavanagh B. Recurrent cervical carcinoma: typical and atypical manifestations. RadioGraphics 19: S103-116, 1999.

21.       Kavanagh BD, Zwicker RD, Segreti EM, Lindquist LA, Fulcher AS, Hundley GM, Spindler JA, Cardinale RM. Digital fluoroscopy for placement verification and treatment planning in gynecologic brachytherapy. Radiology, 215: 900-903, 2000.

22.       Kavanagh BD, Campbell RL, Patterson JW,  O’Neill RL, Cardinale, RM, Kaugars GE. Desmoplastic malignant melanoma of the palatal alveolar mucosa: sustained disease-free survivorship after surgery and post-operative radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol and Endod 89: 465-470,2000.

23.       Manning MA, Cardinale RM, Benedict S, Kavanagh BD, Zwicker R, Amir C, Broaddus WC.  Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 47(3), 603-608, 2000.

24.       Manning MA, Cardinale RM, Schmidt-Ullrich RK, Kavanagh BD, Wornom I, Broaddus WC. Extracorporeal irradiation of tumorous calvaria. J Neurosurgery 93:494-497, 2000.

25.       Kavanagh BD, Khandelwal SR, Schmidt-Ullrich RK, Roberts JD, Pearlman AD, Shaw EG, Venitz J, Dusenbery KE, Abraham DJ, Gerber MJ. A Phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics. Int. J. Radiat. Oncol. Biol. Phys. 49(4): 1133-1139, 2001.

26.       Kavanagh BD, Segreti EM, Koo DT, Amir C, Arthur DW, Wheelock J, Cardinale RM, Schmidt-Ullrich RK. Long-term Local Control and Survival following Concomitant Boost Accelerated Radiotherapy for Locally Advanced Cervix Cancer.  Amer J Clin Oncol 24(1): 113-119, 2001.

27.       Kavanagh BD, Fisher BA, Cardinale RM, Wheelock JB, Segreti EM, Benedict SH, Goram A. Cost analysis of erythropoietin versus blood transfusions for cervix cancer patients receiving chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 51(2): 435-441, 2001.

28.       Manning MA, Wu Q, Mohan R, Lauve A, Kavanagh BD, Morris MM, Schmidt-Ullrich RK. The effect of set-up uncertainty on normal tissue sparing with IMRT for head and neck cancer.  Int. J. Radiat. Oncol. Biol. Phys 51(5): 1400-1409, 2001.

29.       Arnfield MR, Lin PS, Manning MA, Arthur DW, Kavanagh BD, Zwicker RD, Schmidt-Ullrich RK. The effect of high-dose-rate brachytherapy dwell sequence on cell survival. Int. J. Radiat. Oncol. Biol. Phys  2002 Mar 1;52(3):850-7.

30.       Kavanagh BD, Segreti EM, Boardman C, Wheelock J. Radiation Therapy in Gynecology.  eMedicine Journal, April 9, 2002, Vol 3, Number 4. Note: at this time submissions to this publication were peer-reviewed and MEDLINE-referenced, though no longer the case.

31.       Segreti EM, Kavanagh BD. Palliative Care of the Patient with Advanced Gynecologic Cancer.  eMedicine Journal, April 9, 2002, Vol. 3, Number 4. Note: at this time submissions to this publication were peer-reviewed and MEDLINE-referenced, though no longer the case.

32.       Schefter TE, Kavanagh BD, Wu Q, Tong S, Newman F, Arnfield M, Benedict SH, McCourt S, Mohan R.  Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally advanced cervix cancer.  Medical Dosimetry  27(2): 177-184, 2002.

33.       Kavanagh BD, Secomb TW, Hsu R, Lin PS, Venitz J, Dewhirts MW. A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation. Int. J. Radiat. Oncol. Biol. Phys, 2002 May 1;53(1):172-9.

34.       Eley KW, Benedict SH, Chung TDK, Kavanagh BD, Schmidt-Ullrich RKA, Lin PS.  The effect of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic irradiation. Int. J. Radiat. Oncol. Biol. Phys, 2002 Oct 1;54(2):542.

35.       Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, Benedict SH, McCourt S, Mohan R.  Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Seminars in Radiation Oncology 12(3):260-271, 2002.

36.       Kavanagh BD, Timmerman RD,  Benedict SH, et al. How Should We Describe the Radiobiologic Effect of  Extracranial Stereotactic Radiosurgery:  Equivalent Uniform Dose or Tumor Control Probability? Med Phys 2003 Mar;30(3):321-4.

37.       Arthur DA, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, Kavanagh BD, Warwicke LA, Holdford D, Amir C, Schmidt-Ullrich RK. Partial Breast Brachytherapy Following Lumpectomy: low-dose-rate and high-dose-rate experience. Int. J. Radiat. Oncol. Biol. Phys, 2003 Jul 1;56(3):681-9

38.       Schefter TE, Kavanagh BD, Timmerman RD, et al. A Phase I trial of stereotactic body radiation therapy for liver metastases. Int. J. Radiat. Oncol. Biol. Phys 62(5):1371-8, 2005.

39.       Poznanovic SA, Cass SP, Kavanagh BD. Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors. Otolaryngol Head Neck Surg. 2006 Mar;134(3):437-42.

40.       Kavanagh BD, McGarry R, Timmerman RD. Stereotactic body radiation therapy for oligometastases. Seminars in Radiat Oncol, 2006 Apr;16(2):77-84.

41.       Kavanagh BD, Ding M, Schefter TE, Stuhr K, Newman F. The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors. J Appl Clin Med Phys. 2006; 7(2) 58-63.

42.       Ding, M, Newman F, Kavanagh BD, Stuhr K, Johnson TK, Gaspar LE. Comparative dosimetric study of three-dimensional conformal, dynamic conformal arc, and intensity-modulated radiotherapy for brain tumor treatment using the Novalis system. Int J Radiat Oncol Biol Phys. 2006; 66(4 Suppl):S82-6.

43.       Schefter TE, Kavanagh BD, Raben D, et al. A Phase I trial of SBRT for Lung Metastases. Int J Radiat Oncol Biol Phys. 2006;66(4 Suppl):S120-7.

44.       Baisden J, Reish A, Sheng K, Larner J, Kavanagh B, Read P. Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasis. Int. J. Radiat. Oncol. Biol. Phys. 2006 Oct 1;66(2):620-5.

45.       Crawford ED, Kavanagh BD. The role of alpha-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy. Am J Clin Oncol 2006 Oct;29(5):517-23.

46.       Kavanagh BD, Schefter TE, Cardenes HR, et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncologica, 2006; 45(7):848-55.

47.       Ballonoff A, Kavanagh B, Nash R, et al. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol. 2008;47(5):962-70.

48.       Newman F, Asadi-Zeydabadi M, Durairaj VD, Ding M, Stuhr K, Kavanagh BD. Visual Sensations during Radiotherapy to the Orbit: Demonstration of Cherenkov Radiation as Proximate Cause. Medical Physics 2008 Jan;35(1):77-80.

49.       Rusthoven K, Chen C, Raben D, Kavanagh BD. The Use of External Beam Radiotherapy is Associated with a Reduced Incidence of Second Primary Head and Neck Cancers: a SEER Database Analysis. Int. J. Radiat. Oncol. Biol. Phys  71 (1): 192–198, 2008.

50.       Schwer A, Damek D, Kavanagh BD, et al. A phase I dose escalation study of fractionated stereotactic radiosurgery (SRS) in combination with gefitinib in patients with recurrent malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys 2008 Mar 15;70(4):993-1001.

51.       Ding M, Newman F, Gaspar L, Kavanagh B, K Stuhr K, Raben D, Li JS, Ma C-M. 4D treatment planning tool for the evaluation of motion effects on lung cancer treatments. Journal of Physics: Conference Series 102 (2008) 012008.

52.       Ballonoff A, Kavanagh B, McCarter M, et al. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer, a phase II trial. Am J Clin Oncol. 2008 Jun;31(3):264-70.

53.       Rusthoven K, Flaig T, Kavanagh BD. High Incidence of Lung Cancer after Non-Muscle-Invasive Transitional Cell Carcinoma of the Bladder: Implications for Screening Trials. Clinical Lung Cancer 2008 Mar;9(2):106-11

54.       Ballonoff A, Rusthoven K, Schwer A, McCammon R, Kavanagh B, Bassetti M, Newman F, Rabinovitch R. Outcomes and Impact of Radiotherapy in Patients with Stage I or II Diffuse Large B-Cell Lymphoma: A Surveillance, Epidemiology and End Results (SEER) Analysis. Int. J. Radiat. Oncol. Biol. Phys 2008 Dec 1;72(5):1465-71.

55.       McCammon R, Schefter T, Gaspar L, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after Stereotactic  Body Radiation Therapy (SBRT). Int. J. Radiat. Oncol. Biol. Phys 2009 Jan 1;73(1):112-8

56.       Schwer A, Kavanagh BD, McCammon R, Gaspar LE, Kleinschmidt-De Masters BK, Stuhr K, Chen C. Radiographic and Histopathologic Observations after Combined EGFR Inhibition and Hypofractionated Stereotactic Radiosurgery (SRS) in Patients with Recurrent Malignant Gliomas. Int. J. Radiat. Oncol. Biol. Phys 2009 Apr 1;73(5):1352-7.

57.       Olsen CC, Welsh J, Kavanagh BD, et al. Microscopic and Macroscopic Tumor and Parenchymal Effects of Liver Stereotactic Body Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys. 2008 Nov 4. [Epub ahead of print]

58.       Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Rao Devinien V, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuranemi P, Gaspar L. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int. J. Radiat. Oncol. Biol. Phys 2009 Jan 1;73(1):9-14

59.       Rusthoven K, Kavanagh BD, et al. Mature Results of a Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases. J Clin Oncol 2009 Apr 1;27(10):1572-8. Epub 2009 Mar 2.

60.       Rusthoven K, Kavanagh BD, et al. Mature Results of a Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases. J Clin Oncol 2009 Apr 1;27(10):1579-84. Epub 2009 Mar 2.

61.       McCammon R, Rusthoven KE, Kavanagh B, Newell S, Newman F, Raben D. Toxicity assessment of pelvic intensity-modulated radiotherapy with a hypofractionated simultaneous integrated boost to the prostate for intermediate- and high-risk localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):413-20. Epub 2009 Apr 11.

62.       Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, Schefter TE, Kavanagh BD, Larner JM. Chest Wall Volume Receiving More than 30 Gy Predicts Risk of Severe Pain and/or Rib Fracture Following Lung Stereotactic Body Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys. 2009 May 8. [Epub ahead of print]

63.       Pugh TJ, Ballonoff A, Rusthoven KE, McCammon R, Kavanagh B, Newman F, Rabinovitch R. Cardiac Mortality in Patients with Stage I and II Diffuse Large B-Cell Lymphoma Treated with and without Radiation: A Surveillance, Epidemiology, and End-Results Analysis. Int J Radiat Oncol Biol Phys. 2009 Jun 8. [Epub ahead of print]

64.       Dawson LA, Paulino AC, Kavanagh BD, Pan CC, Das SK, Miften M, Li XA, Ten Haken RK, Schultheiss TE. Radiation-associated kidney injury. In press, Int. J. Radiat. Oncol. Biol. Phys.

65.       Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, Miften M. Radiation Dose Volume Effects in the Stomach and Small Bowel. In press, Int. J. Radiat. Oncol. Biol. Phys.

66.       Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, Ten Haken RK. Radiation-Associated Liver Injury. In press, Int. J. Radiat. Oncol. Biol. Phys.

 

Books and monographs:

 

67.    Kavanagh BD, Timmerman RD. Stereotactic Body Radiation Therapy. Philadelphia: Lippincott, Williams & Wilkins, 2005.

68.    Meyer, JF; Kavanagh BD, Purdy JA, Timmerman RD. IMRT, IGRT, SBRT:  Advances in the Treatment Planning and Delivery of Radiotherapy. Frontiers in Radiotherapy and Oncology, Volume 40; Berlin: Karger, 2007.

 

Book chapters:

 

69.    Kavanagh BD, Lyckholm L, Sugarman J. Ethics, Professional Values, and Legal Considerations in Radiation Oncology.  In Principles and Practice of Radiation Oncology, 4th edition, Lippincott, Williams & Wilkins, 2004.

70.    Perez CA, Kavanagh BD. Uterine Cervix Cancer. In Principles and Practice of Radiation Oncology, 4th edition, Lippincott, Williams & Wilkins, 2004.

71.    Lillehei KO, Kavanagh BD.  Brain Metastases from Renal Cell Carcinoma. In Textbook of Neuro-oncology, Berger MS and Prados MD, eds., Elsevier, Inc., 2004.

72.    Schefter T, Kavanagh BD. Case Study in Gynecological IMRT. In Clinical Application of Intensity-Modulated Radiotherapy, Arndt et al, eds. Dekker, 2005.

73.    Kavanagh BD, Cardinale RM. Special Problems in Stereotactic Body Radiation Therapy: Dose Rate Effect, Dose Inhomogeneity, and Target Margin Selection. In Stereotactic Body Radiation Therapy. Lippincott, Williams & Wilkins, 2005.

74.    Wersall JP, Kavanagh BD.  Stereotactic Body Radiation Therapy for Renal Cell Carcinoma.  In Stereotactic Body Radiation Therapy. Lippincott, Williams & Wilkins, 2005.

75.    Schefter TE, Cardenes HR, Kavanagh BD. Stereotactic Body Radiation Therapy For Liver Tumors.  In Stereotactic Body Radiation Therapy. Lippincott, Williams & Wilkins, 2005.

76.    Gurel MH, Kavanagh BD, Moran BJ, Raben A, Raben D. Chapter 21, “Radiation Therapy”. In Prostate Cancer.  Bostwick DG, Crawford ED, Higano CS, Roach M, eds. American Cancer Society, 2005.

77.    Kavanagh BD, Petrylak DP, Vestal JC. Ch 24, “Other Therapies in Use”. In Prostate Cancer.  Bostwick DG, Crawford ED, Higano CS, Roach M, eds. American Cancer Society, 2005.

78.    Kavanagh BD, Lyckholm L, Sugarman J. Ethics, Professional Values, and Legal Considerations in Radiation Oncology.  In Principles and Practice of Radiation Oncology, 5th edition, Lippincott, Williams & Wilkins, 2007.

79.    Perez CA, Kavanagh BD. Uterine Cervix Cancer. In Principles and Practice of Radiation Oncology, 5th edition, Lippincott, Williams & Wilkins, 2007.

80.    Kavanagh BD, Bradley J, Timmerman RD. Stereotactic Irradiation of Tumors outside the Central Nervous System. In Principles and Practice of Radiation Oncology, 5th edition, Lippincott, Williams & Wilkins, 2007.

81.    Medin P, Kavanagh B, Solberg T. Image Guided Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. In Image Guided Adaptive Radiotherapy, Xing and Timmerman, eds. Lippincott Williams & Wilkins, 2009.

82.    Timmerman RD, Solberg T, Kavanagh B, Lo S. Stereotactic Techniques for Lung Cancer Treatment. Principles and Practice of Lung Cancer, 4e. Pass H, et al, eds. Lippincott Williams & Wilkins, 2010.

83.    Rusthoven K, Kavanagh BD. IGRT for Metastatic and Recurrent Disease, in Mundt AJ, Roeske J, eds., Image-Guided Radiation Therapy (IGRT): A Clinical Perspective. Toronto: BC Decker, 2009, in press